Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Optimizing Antimicrobial Stewardship (AMS) Interventions and Outcomes in Clinical Outcomes, Optimal Use and Resource UtilizatioRelease Date:Research Inflammation & Immunology China Optimizing Disease Management to Improve Alopecia Areata Quality of CareRelease Date:Quality Improvement Inflammation & Immunology China Research on Exploring Disease Assessment and Prioritizing Systematic Treatment for VitiligoRelease Date:Research Inflammation & Immunology China Quality Improvement in Molecular Testing Pathways for Metastatic Colorectal Cancer (mCRC)Release Date:Partner: American Society for Clinical Pathology (ASCP)Quality Improvement Oncology USA Personalized monitoring&treatment for HR+, HER2- mBC patients treated w CDK4/6i: incorporating Patient complexity risk factorsRelease Date:Quality Improvement, Research Oncology Italy Providing Appropriate Medical Care for IBD PatientsRelease Date:Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)Quality Improvement Inflammation & Immunology Japan Administration of brentuximab vedotin alone or in combination with other approved agents in pre and/or peri CAR-TRelease Date:Research Oncology USA Fostering Educational Initiatives for ALK+ Metastatic Non-Small Cell Lung Cancer(mNSCLC) Tyrosine Kinase Inhibitors(TKI) TherapyRelease Date:Education Oncology Canada 2026 Inflammatory Bowel Disease (IBD) Fellowship- United StatesRelease Date:Fellowship Inflammation & Immunology USA Title Grant Type Focus Area Country Application Due Date New Mechanisms and Emerging Treatment Options in Metastatic Breast CancerEducation Oncology All Addressing Knowledge Gaps in Aplastic AnemiaRelease Date:Education Hospital All Gene and Gene-modified Cell Therapies Medical EducationRelease Date:Partner: American Society of Gene + Cell TherapyEducation Rare Disease All Education for Improvement of Early Detection and Appropriate Anticoagulant Therapy for Atrial FibrillationRelease Date:Education Internal Medicine Japan Efforts to Improve Quality of Migraine Medical CareRelease Date:Partner: The Japanese Headache SocietyEducation Internal Medicine Japan Pathological diagnosis and Immunohistochemistry biomarker assessments of Breast CancerRelease Date:Quality Improvement Oncology Ghana Evolving Treatment Options in First-line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC)Education Oncology All Promoting Understanding of COVID-19 and Vaccination and Improving Communication Skills for Healthcare ProfessionalsRelease Date:Quality Improvement Vaccines Japan American Headache Society Quality Improvement Competitive Grant ProgramQuality Improvement Internal Medicine USA Boosting Oncology Opportunities for Support programs and Treatment, (BOOST), An Oncology Quality Boosting ProgramRelease Date:Quality Improvement Oncology Netherlands Understanding the Mechanisms and Formulating the Optimal Management of Hematological Toxicity of PARPiRelease Date:Partner: National Comprehensive Cancer NetworkResearch Oncology USA Improving Care for Patients with Recurrent/Metastatic (R/M) Cervical CancerRelease Date:Education Oncology USA